Shares of Clover Health Investments, Corp. (CLOV) are up more than 15% in pre-market on Thursday after the company reported more than 100% growth in second-quarter revenue.
Revenue for the second quarter grew 139.7% to 412.5 million from $172.1 million last year due primarily to the launch of Direct Contracting.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com